| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ATHEROSCLEROSIS.2009.08.029 |
| P698 | PubMed publication ID | 19758589 |
| P50 | author | Olaf Heidenreich | Q42772506 |
| P2093 | author name string | Karin Daub | |
| Tanja Schönberger | |||
| Andreas E May | |||
| Boris Bigalke | |||
| Meinrad Gawaz | |||
| Peter Seizer | |||
| Harald F Langer | |||
| Stephan Lindemann | |||
| Björn F Krämer | |||
| Yared Herouy | |||
| Oliver Borst | |||
| Roland Schmidt | |||
| Michael R Lang | |||
| Moritz Schött | |||
| P433 | issue | 1 | |
| P304 | page(s) | 51-57 | |
| P577 | publication date | 2009-08-21 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation | |
| P478 | volume | 209 |
| Q33598894 | Atorvastatin attenuates plaque vulnerability by downregulation of EMMPRIN expression via COX-2/PGE2 pathway |
| Q64269818 | Comparison of adipose‑ and bone marrow‑derived stem cells in protecting against ox‑LDL‑induced inflammation in M1‑macrophage‑derived foam cells |
| Q39374455 | Cyclophilin A affects inflammation, virus elimination and myocardial fibrosis in coxsackievirus B3-induced myocarditis |
| Q59330226 | Cyclophilin A as a target in the treatment of cytomegalovirus infections |
| Q28822277 | Cyclophilin A enhances macrophage differentiation and lipid uptake in high glucose conditions: a cellular mechanism for accelerated macro vascular disease in diabetes mellitus |
| Q34501451 | Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice |
| Q39525770 | Cyclophilin A promotes human hepatocellular carcinoma cell metastasis via regulation of MMP3 and MMP9. |
| Q92634017 | Cyclophilin A/EMMPRIN Axis Is Involved in Pro-Fibrotic Processes Associated with Thoracic Aortic Aneurysm of Marfan Syndrome Patients |
| Q37577487 | Cyclophilin A: a key player for human disease |
| Q37719732 | Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics |
| Q34780920 | Decrease in plasma cyclophilin A concentration at 1 month after myocardial infarction predicts better left ventricular performance and synchronicity at 6 months: a pilot study in patients with ST elevation myocardial infarction |
| Q92445028 | Diagnostic Performance of Cyclophilin A in Cardiac Surgery-Associated Acute Kidney Injury |
| Q54489626 | Differential MMP-9 activity in CD34⁺progenitor cell-derived foam cells from diabetic and normoglycemic patients. |
| Q41892420 | Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion |
| Q34432435 | Downregulation of cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9. |
| Q92715317 | EMMPRIN-CypA contributes to the inflammatory processes in human periodontitis through infiltrating CD68+ inflammatory cells |
| Q50249518 | Extracellular Cyclophilin A Augments Platelet-Dependent Thrombosis and Thromboinflammation |
| Q50117655 | Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease |
| Q88219288 | Extracellular and Intracellular Cyclophilin A, Native and Post-Translationally Modified, Show Diverse and Specific Pathological Roles in Diseases |
| Q36077903 | Extracellular cyclophilin-A stimulates ERK1/2 phosphorylation in a cell-dependent manner but broadly stimulates nuclear factor kappa B |
| Q35152073 | Function of CD147 in atherosclerosis and atherothrombosis |
| Q43081736 | Functions of cyclophilin A in atherosclerosis |
| Q34206352 | Green fluorescent protein (GFP) color reporter gene visualizes parvovirus B19 non-structural segment 1 (NS1) transfected endothelial modification |
| Q26775999 | How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity |
| Q60951619 | Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension |
| Q57810290 | Non-Invasive Detection of Extracellular Matrix Metalloproteinase Inducer EMMPRIN, a New Therapeutic Target against Atherosclerosis, Inhibited by Endothelial Nitric Oxide |
| Q98289797 | Oxidized low-density lipoprotein inhibits the degradation of cyclophilin A via the lysosome in vascular smooth muscle cells |
| Q35878135 | PPIA rs6850: A > G single-nucleotide polymorphism is associated with raised plasma cyclophilin A levels in patients with coronary artery disease. |
| Q27329947 | Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7 |
| Q35854596 | Proteotoxic stress and circulating cell stress proteins in the cardiovascular diseases. |
| Q92255919 | SP-8356, a Novel Inhibitor of CD147-Cyclophilin A Interactions, Reduces Plaque Progression and Stabilizes Vulnerable Plaques in apoE-Deficient Mice |
| Q38949695 | Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway |
| Q40409465 | Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis. |
| Q53778588 | The roles of CyPA and CD147 in cardiac remodelling. |
| Q35458952 | Tumor-derived microvesicles mediate human breast cancer invasion through differentially glycosylated EMMPRIN. |
Search more.